Weinstein, 68, had argued that his poor health
made giving a deposition "practically impossible," and put him
at "severe risk" of self-incrimination because of pending
criminal charges in Los Angeles.
U.S. District Judge Alvin Hellerstein, however, said Weinstein
did not provide medical support for his health claims, and that
it was unclear when Weinstein's constitutional right against
self-incrimination might no longer be a concern.
"In balance, plaintiffs have suffered injuries from defendant's
conduct, which occurred many years ago, and they are entitled to
vindicate their rights efficiently," Hellerstein wrote. "I find
that a stay is unnecessary. Whether Weinstein invokes the Fifth
Amendment or not is his choice."
Imran Ansari, a lawyer for Weinstein, said in an email that
Weinstein's poor health "frustrates" his ability to defend
himself, and invoking the Fifth Amendment because of the
criminal case could hurt Weinstein's defense in the civil case.
Lawyers for Weinstein's accuser did not immediately respond to
requests for comment.
The class-action case also accused Weinstein, his brother Bob
Weinstein and their bankrupt Weinstein Co of maintaining a
hostile work environment.
In seeking a delay, Weinstein's lawyers said on Nov. 19 that
their client suffered from diabetes mellitus, coronary artery
disease, sleep apnea, anemia, hypertension and other ailments,
though he had not contracted COVID-19.
Weinstein is appealing his February 2020 conviction and 23-year
prison term for sexual assault and rape.
He faces 11 felony charges in Los Angeles, including for rape
and sexual battery, pending an extradition that is now on hold.
Weinstein has denied having nonconsensual sex with anyone.
The case is Geiss et al v Weinstein Co Holdings LLC et al, U.S.
District Court, Southern District of New York, No. 17-09554.
(Reporting by Jonathan Stempel in New York; Editing by Matthew
Lewis)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content
|
|